Sherlock Biosciences, Inc. — Form D
Sherlock Biosciences, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-03-15. The offering totals $80.0M, of which $80.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2022-03-15
- Form: D
- Accession: 0001774717-22-000003
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $80.0M
- Amount sold: $80.0M
- Investors: 13
- Date of first sale: 2022-02-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-437356
Issuer
- Name: Sherlock Biosciences, Inc.
- CIK: 0001774717
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 35 SPINELLI PLACE 35 Spinelli Place, CAMBRIDGE, MA, 02138
- Phone: 617-612-8209
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| James Collins | Director | Cambridge, MA |
| Bryan Dechairo | Director | Brighton, MA |
| Issi Rozen | Director | Cambridge, MA |
| Michael Rubin | Director | Richmond Hill, A6 |
| David Walt | Director | Cambridge, MA |
| Bryan Dechairo | Executive Officer | Brighton, MA |
| David Walt | Related Person | Cambridge, MA |
| Rahul Dhanda | Director | Cambridge, MA |
| Rahul Dhanda | Executive Officer | Cambridge, MA |
| Rahul Dhanda | Related Person | Cambridge, MA |
| James Collins | Related Person | Cambridge, MA |
| Issi Rozen | Related Person | Cambridge, MA |
Other filings by this issuer (1)
More